Search

Veligrotug-vvze (Lumvoa; Viridian Therapeutics Inc.) for Thyroid Eye Disease

An intravenously administered insulin-like growth factor-1 receptor (IGF-1R) inhibitor indicated for the treatment of thyroid eye disease.

Complete this form to request the full report